NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
** Shares of Rua Bioscience RUA.NZ gain 3.6% to A$0.029, their highest level since November 19 ** Medical cannabis firm says it has secured exclusive distribution rights in New Zealand for its dry herb vaporiser device, Oleo Panacea ** Says distribution agreement adds a new product category to co's portfolio alongside the creation of a fresh revenue stream ** Stock up 2.8% YTD, including the day's moves (Reporting by Nikita Maria Jino in Bengaluru) ((Nikita.Jino@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth